Beneficial clinical outcomes resulting from pharmacist interventions.
- Published in:
- Journal of Oncology Pharmacy Practice, 1999, v. 5, n. 4, p. 184, doi. 10.1191/107815599678840471
- By:
- Publication type:
- Article
Works matching IS 10781552 AND DT 1999 AND VI 5 AND IP 4
Results: 6
1
2
Targeted toxins.
- Published in:
- Journal of Oncology Pharmacy Practice, 1999, v. 5, n. 4, p. 149, doi. 10.1191/107815599678840480
- By:
- Publication type:
- Article
3
Thalidomide does not interfere with graft-versus-leukemia reactivity in mice.
- Published in:
- Journal of Oncology Pharmacy Practice, 1999, v. 5, n. 4, p. 179, doi. 10.1191/107815599678840499
- By:
- Publication type:
- Article
4
A retrospective review of gemcitabine use in advanced epithelial ovarian cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 1999, v. 5, n. 4, p. 190, doi. 10.1191/107815599678840507
- By:
- Publication type:
- Article
5
Audit of efficacy of 3 mg versus 1 mg of intravenous granisetron as antiemetic prophylaxis against acute emesis caused by cisplatin or melphalan.
- Published in:
- Journal of Oncology Pharmacy Practice, 1999, v. 5, n. 4, p. 194, doi. 10.1191/107815599678840516
- By:
- Publication type:
- Article
6
Protein kinase C as a target for new anti-cancer agents.
- Published in:
- Journal of Oncology Pharmacy Practice, 1999, v. 5, n. 4, p. 166, doi. 10.1191/107815599678840525
- By:
- Publication type:
- Article